ALIGN TECHNOLOGY, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ALIGN TECHNOLOGY, INC. (ALGN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $45.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $45.56M, a 5.49% decline year-over-year.
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $40.92M, a 9.05% decline year-over-year.
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $44.29M, a 14.00% increase year-over-year.
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $48.38M, a 1.35% decline year-over-year.
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $185.87M, a 7.00% increase from fiscal 2024.
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $173.70M, a 12.78% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $154.03M, a 15.49% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $133.37M, a 16.64% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $45.56M 10-Q · filed 2026-08-05 | $86.48M 10-Q · filed 2026-08-05 | $130.77M derived: sum of 3 quarters · filed 2026-08-05 | $179.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $40.92M 10-Q · filed 2026-05-06 | $85.21M derived: sum of 2 quarters · filed 2026-05-06 | $133.59M derived: sum of 3 quarters · filed 2026-05-06 | $181.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $44.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $92.67M derived: sum of 2 quarters · filed 2026-02-27 | $140.87M derived: sum of 3 quarters · filed 2026-08-05 | $185.87M 10-K · filed 2026-02-27 |
| 2025-09-30 | $48.38M 10-Q · filed 2025-11-05 | $96.58M derived: sum of 2 quarters · filed 2026-08-05 | $141.58M 10-Q · filed 2025-11-05 | $180.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $48.21M 10-Q · filed 2026-08-05 | $93.20M 10-Q · filed 2026-08-05 | $132.05M derived: sum of 3 quarters · filed 2026-08-05 | $181.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $45.00M 10-Q · filed 2026-05-06 | $83.84M derived: sum of 2 quarters · filed 2026-05-06 | $132.88M derived: sum of 3 quarters · filed 2026-05-06 | $179.91M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $38.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $87.89M derived: sum of 2 quarters · filed 2026-02-27 | $134.91M derived: sum of 3 quarters · filed 2026-02-27 | $173.70M 10-K · filed 2026-02-27 |
| 2024-09-30 | $49.04M 10-Q · filed 2025-11-05 | $96.07M derived: sum of 2 quarters · filed 2025-11-05 | $134.85M 10-Q · filed 2025-11-05 | $173.68M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $47.03M 10-Q · filed 2025-08-06 | $85.82M 10-Q · filed 2025-08-06 | $124.64M derived: sum of 3 quarters · filed 2026-02-27 | $164.25M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $38.79M 10-Q · filed 2025-05-08 | $77.62M derived: sum of 2 quarters · filed 2026-02-27 | $117.22M derived: sum of 3 quarters · filed 2026-02-27 | $155.08M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $38.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $78.43M derived: sum of 2 quarters · filed 2026-02-27 | $116.29M derived: sum of 3 quarters · filed 2026-02-27 | $154.03M 10-K · filed 2026-02-27 |
| 2023-09-30 | $39.60M 10-Q · filed 2024-11-05 | $77.46M derived: sum of 2 quarters · filed 2024-11-05 | $115.20M 10-Q · filed 2024-11-05 | $149.88M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $37.86M 10-Q · filed 2024-08-02 | $75.59M 10-Q · filed 2024-08-02 | $110.28M derived: sum of 3 quarters · filed 2025-02-28 | $143.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $37.73M 10-Q · filed 2024-05-03 | $72.42M derived: sum of 2 quarters · filed 2025-02-28 | $105.34M derived: sum of 3 quarters · filed 2025-02-28 | $139.48M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $34.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $67.61M derived: sum of 2 quarters · filed 2025-02-28 | $101.75M derived: sum of 3 quarters · filed 2025-02-28 | $133.37M 10-K · filed 2025-02-28 |
| 2022-09-30 | $32.92M 10-Q · filed 2023-11-03 | $67.06M derived: sum of 2 quarters · filed 2023-11-03 | $98.68M 10-Q · filed 2023-11-03 | $128.52M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $34.14M 10-Q · filed 2023-08-04 | $65.76M 10-Q · filed 2023-08-04 | $95.60M derived: sum of 3 quarters · filed 2024-02-28 | $124.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $31.62M 10-Q · filed 2023-05-05 | $61.46M derived: sum of 2 quarters · filed 2024-02-28 | $89.86M derived: sum of 3 quarters · filed 2024-02-28 | $118.72M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $29.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $58.24M derived: sum of 2 quarters · filed 2024-02-28 | $87.09M derived: sum of 3 quarters · filed 2024-02-28 | $114.34M 10-K · filed 2024-02-28 |
| 2021-09-30 | $28.40M 10-Q · filed 2022-11-04 | $57.26M derived: sum of 2 quarters · filed 2022-11-04 | $84.50M 10-Q · filed 2022-11-04 | $109.76M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $28.86M 10-Q · filed 2022-08-04 | $56.10M 10-Q · filed 2022-08-04 | $81.36M derived: sum of 3 quarters · filed 2023-02-27 | $106.59M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $27.24M 10-Q · filed 2022-05-05 | $52.51M derived: sum of 2 quarters · filed 2023-02-27 | $77.73M derived: sum of 3 quarters · filed 2023-02-27 | $102.74M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $25.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $50.49M derived: sum of 2 quarters · filed 2023-02-27 | $75.50M derived: sum of 3 quarters · filed 2023-02-27 | $98.43M 10-K · filed 2023-02-27 |
| 2020-09-30 | $25.23M 10-Q · filed 2021-11-02 | $50.24M derived: sum of 2 quarters · filed 2021-11-02 | $73.16M 10-Q · filed 2021-11-02 | $93.66M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $25.01M 10-Q · filed 2021-08-04 | $47.93M 10-Q · filed 2021-08-04 | $68.43M derived: sum of 3 quarters · filed 2022-02-25 | $92.61M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $22.93M 10-Q · filed 2021-05-05 | $43.42M derived: sum of 2 quarters · filed 2022-02-25 | $67.60M derived: sum of 3 quarters · filed 2022-02-25 | $90.07M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $20.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $44.67M derived: sum of 2 quarters · filed 2022-02-25 | $67.14M derived: sum of 3 quarters · filed 2022-02-25 | $88.18M 10-K · filed 2022-02-25 |
| 2019-09-30 | $24.18M 10-Q · filed 2020-10-30 | $46.64M derived: sum of 2 quarters · filed 2020-10-30 | $67.69M 10-Q · filed 2020-10-30 | $86.53M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $22.47M 10-Q · filed 2020-07-31 | $43.51M 10-Q · filed 2020-07-31 | $62.36M derived: sum of 3 quarters · filed 2021-02-26 | $81.55M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $21.04M 10-Q · filed 2020-05-05 | $39.89M derived: sum of 2 quarters · filed 2021-02-26 | $59.09M derived: sum of 3 quarters · filed 2021-02-26 | $75.98M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $18.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $38.04M derived: sum of 2 quarters · filed 2021-02-26 | $54.93M derived: sum of 3 quarters · filed 2021-02-26 | $70.76M 10-K · filed 2021-02-26 |
| 2018-09-30 | $19.20M 10-Q · filed 2019-10-31 | $36.09M derived: sum of 2 quarters · filed 2019-10-31 | $51.92M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $16.89M 10-Q · filed 2019-08-01 | $32.72M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $15.83M 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $58.85M 10-K · filed 2020-02-28 | |||
| 2016-12-31 | $54.15M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $52.94M 10-K · filed 2018-02-28 | |||
| 2014-12-31 | $39.82M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $26.44M 10-K · filed 2016-02-25 | |||
| 2012-12-31 | $21.48M 10-K · filed 2015-02-26 | |||
| 2011-12-31 | $19.16M 10-K · filed 2014-02-28 | |||
| 2010-12-31 | $16.07M 10-K · filed 2013-03-01 | |||
| 2009-12-31 | $15.09M 10-K · filed 2012-02-29 | |||
| 2008-12-31 | $17.06M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |